Clinical trials show that Semaglutide is a promising option for treating PCOS, as it helps with weight loss, improves insulin sensitivity, and normalizes menstrual cycles
Understanding the effects of cardiometabolic health can be affected following discontinuation of semaglutide use, which can increase risk factors for obesity-related diseases such as diabetes and hypertension
The drivers of the warning letters Furman provided a breakdown of the principal factors behind the increase, per the RAPS report: Roughly 22% of warning letters targeted telehealth platforms marketing compounded drug products with false or misleading claims, including companies promoting compounded versions of GLP-1 (glucagon-like peptide-1) diabetes or weight-loss drugs
Greater Sexual Arousal Low estrogen levels can diminish your sex drive and lead to low libido
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet approved by the MHRA or EMA, with Phase 3 trials ongoing
Some are also sold on Amazon or through third-party pharmacy distributors that offer diabetes supplies for home delivery